Authors
Loading...
Nested case-control study investigates PFAS exposure impacts on TGCC risk, highlighting endocrine disruptor concerns.
Uldbjerg et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: